US Stock MarketDetailed Quotes

CERO CERo Therapeutics

Watchlist

0.193
-0.009-4.60%

Close Nov 29 13:00 ET

0.194
+0.001+0.36%

Post 16:49 ET

29.01MMarket Cap-51P/E (TTM)

CERo Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q1)Mar 31, 2022

(FY)Dec 31, 2021

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-1.32M

-2.07M

62.14%-1.44M

-16.00%-11.71M

-3.79M

-10.09M

Net income from continuing operations

---1.49M

---2.09M

30.64%-2.44M

-11.28%-11.83M

---3.52M

---10.63M

Operating gains losses

---186.07K

---261.82K

339.17%36.66K

96.23%-36.99K

---15.33K

---980.31K

Depreciation and amortization

--281.41K

--277.45K

8.81%273.58K

45.87%1.07M

--251.43K

--735.47K

Other non cash items

--13.95K

----

Change In working capital

--42.46K

---35.5K

203.94%663.27K

-363.45%-1.3M

---638.13K

--492.34K

-Change in prepaid assets

--26.73K

---75.14K

167.91%90.1K

-49.26%49.59K

---132.68K

--97.73K

-Change in payables and accrued expense

--185.73K

--203.37K

299.99%733.03K

-210.47%-761.42K

---366.53K

--689.26K

-Change in other current liabilities

---170K

---163.73K

-15.07%-159.86K

-98.63%-585.25K

---138.92K

---294.65K

Cash from discontinued investing activities

Operating cash flow

---1.32M

---2.07M

62.14%-1.44M

-16.00%-11.71M

---3.79M

---10.09M

Investing cash flow

Cash flow from continuing investing activities

-13.33%-694.23K

-409.98K

-612.57K

Net PPE purchase and sale

----

-13.33%-694.23K

---409.98K

---612.57K

Cash from discontinued investing activities

Investing cash flow

----

-13.33%-694.23K

---409.98K

---612.57K

Financing cash flow

Cash flow from continuing financing activities

-1

566.51K

5.17K

-90.66%5.63K

60.26K

Net issuance payments of debt

--0

--605.23K

--0

----

Net preferred stock issuance

--0

----

Proceeds from stock option exercised by employees

--0

--600

--5.17K

-90.66%5.63K

--0

--60.26K

Net other financing activities

---1

----

Cash from discontinued financing activities

Financing cash flow

---1

--566.51K

--5.17K

-90.66%5.63K

--0

--60.26K

Net cash flow

Beginning cash position

--3.88M

--5.39M

-64.51%6.82M

-35.65%19.22M

--19.22M

--29.86M

Current changes in cash

---1.32M

---1.51M

65.95%-1.43M

-16.45%-12.4M

---4.2M

---10.65M

End cash Position

--2.56M

--3.88M

-64.11%5.39M

-64.51%6.82M

--15.01M

--19.22M

Free cash flow

---1.32M

---2.07M

65.83%-1.44M

-15.85%-12.4M

---4.2M

---10.71M

Currency Unit

USD

	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q1)Mar 31, 2022	(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-1.32M	-2.07M	62.14%-1.44M	-16.00%-11.71M	-3.79M	-10.09M
Net income from continuing operations	---1.49M	---2.09M	30.64%-2.44M	-11.28%-11.83M	---3.52M	---10.63M
Operating gains losses	---186.07K	---261.82K	339.17%36.66K	96.23%-36.99K	---15.33K	---980.31K
Depreciation and amortization	--281.41K	--277.45K	8.81%273.58K	45.87%1.07M	--251.43K	--735.47K
Other non cash items	--13.95K	----	----	----	----	----
Change In working capital	--42.46K	---35.5K	203.94%663.27K	-363.45%-1.3M	---638.13K	--492.34K
-Change in prepaid assets	--26.73K	---75.14K	167.91%90.1K	-49.26%49.59K	---132.68K	--97.73K
-Change in payables and accrued expense	--185.73K	--203.37K	299.99%733.03K	-210.47%-761.42K	---366.53K	--689.26K
-Change in other current liabilities	---170K	---163.73K	-15.07%-159.86K	-98.63%-585.25K	---138.92K	---294.65K
Cash from discontinued investing activities
Operating cash flow	---1.32M	---2.07M	62.14%-1.44M	-16.00%-11.71M	---3.79M	---10.09M
Investing cash flow
Cash flow from continuing investing activities				-13.33%-694.23K	-409.98K	-612.57K
Net PPE purchase and sale	----	----	----	-13.33%-694.23K	---409.98K	---612.57K
Cash from discontinued investing activities
Investing cash flow	----	----	----	-13.33%-694.23K	---409.98K	---612.57K
Financing cash flow
Cash flow from continuing financing activities	-1	566.51K	5.17K	-90.66%5.63K	0	60.26K
Net issuance payments of debt	--0	--605.23K	--0	----	----	----
Net preferred stock issuance	--0	--0	--0	----	----	----
Proceeds from stock option exercised by employees	--0	--600	--5.17K	-90.66%5.63K	--0	--60.26K
Net other financing activities	---1	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	---1	--566.51K	--5.17K	-90.66%5.63K	--0	--60.26K
Net cash flow
Beginning cash position	--3.88M	--5.39M	-64.51%6.82M	-35.65%19.22M	--19.22M	--29.86M
Current changes in cash	---1.32M	---1.51M	65.95%-1.43M	-16.45%-12.4M	---4.2M	---10.65M
End cash Position	--2.56M	--3.88M	-64.11%5.39M	-64.51%6.82M	--15.01M	--19.22M
Free cash flow	---1.32M	---2.07M	65.83%-1.44M	-15.85%-12.4M	---4.2M	---10.71M
Currency Unit	USD	USD	USD	USD	USD	USD

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data